Clinical Trial Update: Third-line Therapy of Multiple Myeloma a Prospective Phase I /II Trial [Phase 1, Phase 2]

View source ↗

Summary

A prospective Phase 1/2 clinical trial evaluating a third-line therapy for multiple myeloma, sponsored by the University of Regensburg; current status is unknow…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Snippet

Sponsor: University of Regensburg | Conditions: Multiple Myeloma | Phase 1, Phase 2 | Status: UNKNOWN